BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 2195189)

  • 1. [Impaired glutathione metabolism in hemolytic anemia].
    Kondo T
    Rinsho Byori; 1990 Apr; 38(4):355-9. PubMed ID: 2195189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemolytic anemia due to abnormalities in erythrocyte nucleotide metabolism].
    Masuda M; Mizoguchi H
    Nihon Rinsho; 1996 Sep; 54(9):2473-7. PubMed ID: 8890581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemolytic anemias caused by erythrocyte enzyme disorders].
    Maldonado Martín A; Mederer Hengstl S; Gil Extremera B
    An Med Interna; 1989 May; 6(5):266-73. PubMed ID: 2491542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemolytic anemia caused by pyrimidine 5'-nucleotidase (P5N) deficiency 15 years later. Apropos of 2 new cases of hereditary deficit and another one of lead poisoning].
    de la Serna FJ; Gilsanz F; Ricard P; Urrutia A
    Med Clin (Barc); 1989 Oct; 93(10):380-2. PubMed ID: 2558262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel mouse model of severe glucose-6-phosphate dehydrogenase (G6PD)-deficiency for in vitro and in vivo assessment of hemolytic toxicity to red blood cells.
    Ko CH; Li K; Li CL; Ng PC; Fung KP; James AE; Wong RP; Gu GJ; Fok TF
    Blood Cells Mol Dis; 2011 Oct; 47(3):176-81. PubMed ID: 21839656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency: nucleotide inhibition of G6PD and the pentose phosphate shunt.
    Tomoda A; Noble NA; Lachant NA; Tanaka KR
    Blood; 1982 Nov; 60(5):1212-8. PubMed ID: 6289944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
    Hohl RJ; Kennedy EJ; Frischer H
    J Lab Clin Med; 1991 Apr; 117(4):325-31. PubMed ID: 1901343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein -SH groups in redox homeostasis--the erythrocyte as a model system.
    Di Simplicio P; Cacace MG; Lusini L; Giannerini F; Giustarini D; Rossi R
    Arch Biochem Biophys; 1998 Jul; 355(2):145-52. PubMed ID: 9675020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylamine treatment increases glutathione-protein and protein-protein binding in human erythrocytes.
    Spooren AA; Evelo CT
    Blood Cells Mol Dis; 1997 Dec; 23(3):323-36. PubMed ID: 9398534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes of antioxidant enzyme activities, glutathione status and lipid peroxidation in rat erythrocytes after heat stress.
    Oztürk O; Gümüşlü S
    Life Sci; 2004 Aug; 75(13):1551-65. PubMed ID: 15261761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte membrane protein changes in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease: an example of postsynthetic modification of membrane proteins.
    Allen DW; Flynn TP; Johnson GJ
    Prog Clin Biol Res; 1982; 97():33-43. PubMed ID: 7156168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age.
    Oztürk O; Gümüşlü S
    Exp Gerontol; 2004 Feb; 39(2):211-6. PubMed ID: 15036414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance.
    Tang HY; Ho HY; Wu PR; Chen SH; Kuypers FA; Cheng ML; Chiu DT
    Antioxid Redox Signal; 2015 Mar; 22(9):744-59. PubMed ID: 25556665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood red-cell enzymes and reduced glutathione in Indian neonates, normal and with pathologic jaundice.
    Pati HP; Singh M; Paul VK; Gupta RK; Saraya AK
    J Trop Med Hyg; 1990 Aug; 93(4):290-4. PubMed ID: 2391727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oxidant stress in lawsone-induced hemolytic anemia.
    McMillan DC; Sarvate SD; Oatis JE; Jollow DJ
    Toxicol Sci; 2004 Dec; 82(2):647-55. PubMed ID: 15456924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
    Grieger M; Schippel W; Siems W; Leppin K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):704-15. PubMed ID: 6198254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Jacobasch G; Bleiber R; Schönian G
    Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine 5'-nucleotidase and oxidative damage in red blood cells transfused to beta-thalassemic children.
    David O; Sacchetti L; Vota MG; Comino L; Perugini L; Pescarmona GP
    Haematologica; 1990; 75(4):313-8. PubMed ID: 2276676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
    Wang YM; Patterson JH; Van Eys J
    J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell enzymes.
    Prchal JT; Gregg XT
    Hematology Am Soc Hematol Educ Program; 2005; ():19-23. PubMed ID: 16304354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.